240 filings
Page 2 of 12
8-K
xkhfdhfhag4driy5
7 Sep 23
CRISPR Therapeutics Announces Leadership Transition
8:39am
S-8
dq1ha
7 Aug 23
Registration of securities for employees
4:18pm
8-K
53ci0mac
7 Aug 23
Results of Operations and Financial Condition
4:07pm
8-K
2bhd640f zld
9 Jun 23
Departure of Directors or Certain Officers
4:29pm
8-K
r98i1hixx1o2gvvibzc
9 Jun 23
Regulation FD Disclosure
7:07am
DEFA14A
p99ihmwe74ygfnx
18 May 23
Additional proxy soliciting materials
4:16pm
8-K
w79bjlej2gs7w5yz6s
8 May 23
Results of Operations and Financial Condition
4:06pm
ARS
3o2t3yqfjvfvh
26 Apr 23
Annual report to shareholders
4:38pm
DEFA14A
aj4h9a8l7s
26 Apr 23
Additional proxy soliciting materials
4:26pm
8-K
ho6 mp2d6pamue5
3 Apr 23
Regulation FD Disclosure
8:10am
8-K
l8doy80leok05d2tp2
29 Mar 23
CRISPR Therapeutics Announces Departure of Board Member
8:08am
8-K
lbo8yj6yjg929563fy
27 Mar 23
Entry into a Material Definitive Agreement
8:08am
8-K
ngzqdhnkz2kp z6fx
14 Mar 23
CRISPR Therapeutics Announces Transition of Chief Financial Officer
8:15am
8-K
vnhgh
21 Feb 23
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
4:06pm